22 July 2022
PharmEasy has momentarily given up on its effort to go public. The company is aiming to raise $200 million through a private placement, albeit at a lower valuation than before. This implies that it will now provide investors a larger stake than before for raising the same amount of money. Some estimates place the corporation's willingness to accept a 25% valuation reduction.